COMPARISON OF PURE ANTIBODY-MEDIATED REJECTION WITH MIXED CELLULAR AND ANTIBODY-MEDIATED REJECTION IN REGARDS TO THE PATHOLOGICAL FEATURES, DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTS

dc.contributor.authorOzdemir, B. Handan
dc.contributor.authorTerzi, Aysen
dc.contributor.authorAyva, Sebnem
dc.contributor.authorSade, L. Elif
dc.contributor.authorBasturk, Bilkay
dc.contributor.authorSezgin, Atilla
dc.date.accessioned2021-03-08T13:19:10Z
dc.date.available2021-03-08T13:19:10Z
dc.date.issued2020
dc.description.sponsorshipTransplantat Soc; Int Liver Transplant Socen_US
dc.identifier.endpageS91en_US
dc.identifier.issn0041-1337en_US
dc.identifier.issue9en_US
dc.identifier.startpageS91en_US
dc.identifier.urihttp://hdl.handle.net/11727/5546
dc.identifier.volume104en_US
dc.identifier.wos000618872100120en_US
dc.language.isoengen_US
dc.relation.journalTRANSPLANTATIONen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleCOMPARISON OF PURE ANTIBODY-MEDIATED REJECTION WITH MIXED CELLULAR AND ANTIBODY-MEDIATED REJECTION IN REGARDS TO THE PATHOLOGICAL FEATURES, DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTSen_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: